Trial intelligence / Profile preview

Dexmedetomidine + Levobupivacaine in Pectoral Nerve Block for Mastectomy

NCT03456661Phase 4Terminated

Start
May 2014
Primary completion
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms). Primary endpoint: Total postoperative opioid (morphine) consumption at 24 hours. Started May 2014; status: terminated.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03456661.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03456661.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call